CCI
TECH icon

Credit Capital Investments’s Bio-Techne TECH Stock Holding History

Credit Capital Investments’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,461
Closed -$405K – 72
2023
Q1 		$405K Buy
+5,461
New +$421K 0.53% 45
2022
Q4 		– Sell
-4,000
Closed -$284K – 79
2022
Q3 		$284K Buy
+4,000
New +$346K 0.38% 47

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Credit Capital Investments's TECH Position: Q2 2023 in Review

Credit Capital Investments sold out of Bio-Techne (TECH) in Q2 2023, closing a stake of 5,461 shares — an estimated $405K sold.

Credit Capital Investments first reported a position in TECH in Q3 2022 and held it in 2 quarters. The position peaked at $405K in Q1 2023. 528 funds tracked by Wall St. Rank hold TECH as of Q2 2023.

  • Credit Capital Investments reported no remaining Bio-Techne position as of Q2 2023 after selling out during the quarter.
  • Credit Capital Investments sold 5,461 Bio-Techne shares in Q2 2023, an estimated $405K.
  • Credit Capital Investments first reported a position in Bio-Techne in Q3 2022 and held it in 2 quarters.
  • Credit Capital Investments's Bio-Techne position peaked at $405K in Q1 2023.
  • 528 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2023.

Based on Credit Capital Investments's 13F filing for Q2 2023, filed 14 Aug 2023.